Table 4.

Outcomes of the included studies.

Authors [Ref.]	Lesions SUVmax	Lesions Site	Detection Rate
Lütje et al. [17]	Range: 3.3–39.7	local recurrence lymph node bone soft tissue	Per patient: 83.3%
De Vries et al. [18]	Range: 0.85–10.56	lymph nodes lungs liver leptomeningeal	Per patient: 100%
Lawhn-Heath et al. [19]	Range: 1.0–27.8	local recurrence lymph node lungs bone	Per patient: 72.7% Per lesion: 65.1%
Verma et al. [20]	Range: 10.1–45.67	Lungs bone	Per patient: 55% Per lesion: 64%
Pitalua-Cortes et al. [21]	Range: 1.8–70.5	lymph nodes lung bone brain	Per patient: 100%
Wächter et al. [22]	Range: 1.3–6.3	local recurrence lymph node lung bone	Per patient: 25%

Legend: SUV_max: maximal standardized uptake value.